glp-1 obesity drug news today drugs Market Overview: GLP-1 Agonists and the Obesity Market Pharma Giants Bet on Next-Generation

Ozempic generally wins for sheer weight loss numbers it delivers 1015% body weight reduction (sometimes more), while Contrave typically lands at 510%

2022;14:e21536

Bkdal TA, Borregaard J, Donsmark M, et al

matched for mean body weight at the start of treatment at 770 g 10 g) received daily IP injections of vehicle (1 mL/kg), sCT (3 g/kg), liraglutide (50 g/kg), a combination of sCT and liraglutide (3 g/kg + 50 g/kg) or a stepwise administration of the amylin and GLP-1R analogs, where rats received sCT treatment for the first week, liraglutide treatment for the second week, followed by a combination treatment of sCT and liraglutide for the remaining testing period

Nutrients, 16(17), 2886